First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to FOLFIRINOX
Related studies linked through entity extraction aliases.
FOLFIRINOX Followed by Ipilimumab With Pancreatic Tumor Vaccine in Treatment of Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Randomized Phase II/Genomic Trial of Two Chemotherapy Regimens in Patients With Resected Pancreatic Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in Patients
- Status
- COMPLETED
- Phase
- PHASE2
Pancreatic Tumor Cell Vaccine (GVAX), Cyclophosphamide, SBRT, and FOLFIRINOX in Patients With Resected Adenocarcinoma of the Pancreas
- Status
- COMPLETED
- Phase
- PHASE2
FOLFIRINOX + RT for Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Modified FOLFIRINOX in Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Intensified Chemotherapy in CRC After Resection of Liver Metastases
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3